A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity

被引:1
|
作者
Patki, P [1 ]
机构
[1] Maharashtra Med Fdn, Dept Urol, Pune, Maharashtra, India
[2] St Peters Hosp, Chertsey, England
关键词
D O I
10.1111/j.1464-410X.2006.06081_3.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:414 / 414
页数:1
相关论文
共 50 条
  • [21] CLINICAL EFFICACY OF A NEW BOTULINUM TOXIN TYPE A FREE OF COMPLEXING PROTEINS IN THE TREATMENT OF REFRACTORY NEUROGENIC AND IDIOPATHIC DETRUSOR OVERACTIVITY
    Yokoyama, Teruhiko
    Ohira, Shin
    Fujita, Masaichiro
    Fukumoto, Kazuhiko
    Fujii, Tomohiro
    Jo, Yoshimasa
    Miyaji, Yoshiyuki
    Nagai, Atsushi
    Oguma, Keiji
    JOURNAL OF UROLOGY, 2012, 187 (04): : E478 - E478
  • [22] Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence:: A prospective nonrandomized study
    Werner, M
    Schmid, DM
    Schüssler, B
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (05) : 1735 - 1740
  • [23] Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity
    Schmid, D. M.
    Roy, S.
    Sulser, T.
    Scheiner, D.
    BJU INTERNATIONAL, 2008, 102 : 7 - 10
  • [24] Trigonal injection of botulinum toxin type A does not cause vesicoureteral reflux in patients with refractory neurogenic detrusor overactivity
    Gomes, C.
    Mascarenhas, F.
    Cocuzza, M.
    NEUROUROLOGY AND URODYNAMICS, 2007, 26 (05) : 733 - 734
  • [25] Botulinum toxin type?A injection for neurogenic detrusor overactivity: Clinical outcome in Japanese patients
    Hikita, Katsuya
    Honda, Masashi
    Kawamoto, Bunya
    Panagiota, Tsounapi
    Inoue, Seiya
    Hinata, Nobuyuki
    Muraoka, Kuniyasu
    Takenaka, Atsushi
    INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (01) : 94 - 99
  • [26] Clinical effects of suburothelial injection of botulinum a toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics
    Kuo, HC
    UROLOGY, 2005, 66 (01) : 94 - 98
  • [27] Letter to the Editor Re 'Intravesical botulinum type-A toxin (Dysport®) in the treatment of idiopathic detrusor overactivity in child'
    Harper, Luke
    JOURNAL OF PEDIATRIC UROLOGY, 2014, 10 (04) : 786 - 786
  • [28] Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: A prospective randomized study
    Giannantoni, A
    Di Stasi, SM
    Stephen, RL
    Bini, V
    Costantini, E
    Porena, M
    JOURNAL OF UROLOGY, 2004, 172 (01): : 240 - 243
  • [29] Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity
    Veeratterapillay, Rajan
    Harding, Chris
    Teo, Luke
    Vasdev, Nikhil
    Abroaf, Ahmed
    Dorkin, Trevor J.
    Pickard, Robert S.
    Hasan, Tahseen
    Thorpe, Andrew C.
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (02) : 175 - 178
  • [30] Efficacy of repeated injections of botulinum toxin-A in patients with overactive bladder and idiopathic detrusor overactivity
    Dowson, Christopher
    Sahai, Arun
    Roux, Jacques
    Watkins, Jane
    Khan, Mohammad S.
    Dasgupta, Prokar
    JOURNAL OF UROLOGY, 2008, 179 (04): : 441 - 441